Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

MedPage Today) — At the American Society of Hematology annual meeting, a roundtable discussion highlighted the evolving role of minimal residual disease (MRD) as a treatment endpoint in multiple myeloma, exploring its implications for therapy…
Read More